Substance / Medication

Pantoprazole sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Pharmacokinetics, Bioequivalence, and Safety Studies of Pantoprazole Sodium Enteric-Coated Tablets in Healthy Subjects.
Chen Zhimin, Gan Fangliang, Rao Xiali et al. · Clin Pharmacol Drug Dev · 2021
PMID: 33128847Observational
Preparation and Characterization of a Novel Aqueous Dispersion for Enteric Coating of Pantoprazole Sodium Pellets.
Han Min, Yu Qin, Liu Xuerong et al. · Acta Pharm · 2018
PMID: 31259710Observational
Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates.
Salama F, El-Abasawy N, Abdel Razeq S A et al. · J Pharm Biomed Anal · 2003
PMID: 14550860Observational
Pantoprazole sodium-induced hyponatremia in a frail elderly adult.
Naharcý Mehmet Ilkin, Cintosun Umit, Ozturk Ahmet et al. · J Am Geriatr Soc · 2014
PMID: 24731036Case Report
Analytical Methods Developed for the Determination of Pantoprazole Sodium: Overview.
Kurt Cucu Aysen · Crit Rev Anal Chem · 2025
PMID: 40517283Review
pH-Sensitive acrylic acid grafted Abelmoschus esculentus composite for sustained release of pantoprazole sodium.
Basharat Maryam, Noreen Sobia, Ghumman Shazia Akram et al. · Eur J Pharm Biopharm · 2025
PMID: 40939770Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pantoprazole sodium (substance)
SNOMED CT
116510001
UMLS CUI
C0795650

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.